Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Biomarkers
- Cancer
- Thromboembolism
- Thrombosis
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The main aims will be the following: Evaluate the utility of the combination of thrombosis biomarkers (D-dimers and thrombin generation potential) with the Khorana score in order to stratify VTE risk in ambulatory cancer patients; Determine the potential of this new score in the stratification of ca...
The main aims will be the following: Evaluate the utility of the combination of thrombosis biomarkers (D-dimers and thrombin generation potential) with the Khorana score in order to stratify VTE risk in ambulatory cancer patients; Determine the potential of this new score in the stratification of cancer patients into high- and low-risk VTE groups, in order to identify patients who would benefit from primary thromboprophylaxis; Determine the applicability of the thrombin generation test as an independent factor in the stratification of VTE risk in the cancer population under study; Determine the predictive value of D-dimers in the cancer population under study (high versus low risk discrimination).
Tracking Information
- NCT #
- NCT04301362
- Collaborators
- LEO Pharma
- Diagnostica Stago
- Investigators
- Principal Investigator: David Ferreira, MD Centro Hospitalar Vila Nova de Gaia/Espinho
Get Well Soon